XML 61 R52.htm IDEA: XBRL DOCUMENT v3.21.1
License Agreements (Details)
£ in Thousands, $ in Thousands
1 Months Ended
Mar. 31, 2018
GBP (£)
Mar. 31, 2016
USD ($)
shares
Sep. 30, 2014
shares
Mar. 31, 2021
USD ($)
Mar. 31, 2021
GBP (£)
Dec. 31, 2020
USD ($)
Schedule Of License Agreements            
Shares issued (in shares) | shares   313,971        
Accrued license fees payable £ 350     $ 206   $ 205
Product Sales | Minimum            
Schedule Of License Agreements            
Conditional payment, regulatory approval (gbp per share)         £ 1,000  
Product Sales | Maximum            
Schedule Of License Agreements            
Conditional payment, regulatory approval (gbp per share)         18,500  
UCL Business plc            
Schedule Of License Agreements            
Shares issued (in shares) | shares     1,497,643      
Payment of upfront fees (usd/gbp per share) £ 1,500 $ 300        
UCL Business plc | Clinical Activities            
Schedule Of License Agreements            
Conditional payment, regulatory approval (gbp per share)         180  
UCL Business plc | Regulatory Approval            
Schedule Of License Agreements            
Conditional payment, regulatory approval (gbp per share)         37,500  
UCL Business plc | Product Sales            
Schedule Of License Agreements            
Conditional payment, regulatory approval (gbp per share)         18,000  
UCL Business plc | Net Sales Levels            
Schedule Of License Agreements            
Conditional payment, regulatory approval (gbp per share)         £ 51,000